4Beppu T, Ogawa M, Yamanaka T, et, al. Clinical evaluation of Azasetron Hydrochloride:a new selective 5-HT3 receptor antagonist--antiemetic profile and plasma concentration in transcatheter arterial chemoembolization using CDDP for unresectable hepatocellular carcinoma[ J ].Can To Kagaku Ryoho, 1998,25 (8) :1197-1202.
5Kimura E, Nilmi S, Watanabe A, et, al. Clinical effect of two azasetmn treatment methods against nausea and vomiting inducedby anticancer drugs including CDDP[ J ]. Gan To Kagaku Ryoho,1997,24(7) : 855-859.
6Kimura E, Niimi S, Watanabe A, et, al. Study on clinical effect of a continuous intravenous infusion of azasetron against nausea and vomiting induced by anticancer drugs including CDDP[J]. Can To Kagalm Ryoho,1996,2,3(4) : 477-481.
